DK3470414T3 - Benzodiazepinderivat med aktivitet på centralnerve- og karsystemerne - Google Patents
Benzodiazepinderivat med aktivitet på centralnerve- og karsystemerne Download PDFInfo
- Publication number
- DK3470414T3 DK3470414T3 DK17732729.3T DK17732729T DK3470414T3 DK 3470414 T3 DK3470414 T3 DK 3470414T3 DK 17732729 T DK17732729 T DK 17732729T DK 3470414 T3 DK3470414 T3 DK 3470414T3
- Authority
- DK
- Denmark
- Prior art keywords
- activity
- central nervous
- vessel systems
- benzodiazepin
- derivative
- Prior art date
Links
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical class N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CUP2016000058A CU20160058A7 (es) | 2016-05-04 | 2016-05-04 | Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular |
| PCT/CU2017/050002 WO2017190713A1 (es) | 2016-05-04 | 2017-05-03 | Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3470414T3 true DK3470414T3 (da) | 2022-01-17 |
Family
ID=59215419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17732729.3T DK3470414T3 (da) | 2016-05-04 | 2017-05-03 | Benzodiazepinderivat med aktivitet på centralnerve- og karsystemerne |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11098039B2 (da) |
| EP (1) | EP3470414B1 (da) |
| JP (1) | JP7078959B2 (da) |
| KR (1) | KR102428383B1 (da) |
| CN (1) | CN110114356B (da) |
| AR (1) | AR108369A1 (da) |
| AU (1) | AU2017259748B2 (da) |
| BR (1) | BR112018072588B1 (da) |
| CA (1) | CA3023105C (da) |
| CL (1) | CL2018003113A1 (da) |
| CU (1) | CU20160058A7 (da) |
| DK (1) | DK3470414T3 (da) |
| EA (1) | EA201892461A1 (da) |
| ES (1) | ES2902992T3 (da) |
| MX (1) | MX385439B (da) |
| MY (1) | MY199288A (da) |
| SG (1) | SG11201809845TA (da) |
| SI (1) | SI3470414T1 (da) |
| WO (1) | WO2017190713A1 (da) |
| ZA (1) | ZA201808162B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU20190114A7 (es) | 2019-12-26 | 2021-08-06 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física |
| CA3164091A1 (en) | 2019-12-26 | 2021-07-15 | Centro De Investigacion Y Desarrollo De Medicamentos Cidem | Use of a benzodiazepine derivative and method of treatment of traumatic brain injury |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009137462A2 (en) * | 2008-05-05 | 2009-11-12 | Envivo Pharmaceuticals, Inc. | Methods for treating cognitive disorders using inhibitors of histone deacetylase |
| CU20090172A7 (es) | 2009-10-09 | 2011-10-05 | Ct De Investigación Y Desarrollo De Medicamentos | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| CU24576B1 (es) | 2016-05-04 | 2022-02-04 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular |
-
2016
- 2016-05-04 CU CUP2016000058A patent/CU20160058A7/xx unknown
-
2017
- 2017-05-03 KR KR1020187035040A patent/KR102428383B1/ko active Active
- 2017-05-03 SI SI201731044T patent/SI3470414T1/sl unknown
- 2017-05-03 EP EP17732729.3A patent/EP3470414B1/en active Active
- 2017-05-03 MY MYPI2018704116A patent/MY199288A/en unknown
- 2017-05-03 WO PCT/CU2017/050002 patent/WO2017190713A1/es not_active Ceased
- 2017-05-03 SG SG11201809845TA patent/SG11201809845TA/en unknown
- 2017-05-03 JP JP2019510748A patent/JP7078959B2/ja active Active
- 2017-05-03 EA EA201892461A patent/EA201892461A1/ru unknown
- 2017-05-03 CA CA3023105A patent/CA3023105C/en active Active
- 2017-05-03 AU AU2017259748A patent/AU2017259748B2/en not_active Ceased
- 2017-05-03 ES ES17732729T patent/ES2902992T3/es active Active
- 2017-05-03 DK DK17732729.3T patent/DK3470414T3/da active
- 2017-05-03 US US16/099,116 patent/US11098039B2/en active Active
- 2017-05-03 MX MX2018013405A patent/MX385439B/es unknown
- 2017-05-03 BR BR112018072588-9A patent/BR112018072588B1/pt active IP Right Grant
- 2017-05-03 CN CN201780041572.6A patent/CN110114356B/zh active Active
- 2017-05-04 AR ARP170101152A patent/AR108369A1/es unknown
-
2018
- 2018-10-31 CL CL2018003113A patent/CL2018003113A1/es unknown
- 2018-12-03 ZA ZA2018/08162A patent/ZA201808162B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210025137A (ko) | 2021-03-09 |
| US11098039B2 (en) | 2021-08-24 |
| CN110114356A (zh) | 2019-08-09 |
| SI3470414T1 (sl) | 2022-03-31 |
| MY199288A (en) | 2023-10-24 |
| CU20160058A7 (es) | 2017-12-08 |
| WO2017190713A1 (es) | 2017-11-09 |
| BR112018072588A2 (pt) | 2019-02-19 |
| ZA201808162B (en) | 2021-08-25 |
| EP3470414A1 (en) | 2019-04-17 |
| JP2019519600A (ja) | 2019-07-11 |
| US20190270738A1 (en) | 2019-09-05 |
| CA3023105A1 (en) | 2017-11-09 |
| CL2018003113A1 (es) | 2019-04-12 |
| MX2018013405A (es) | 2019-08-16 |
| CA3023105C (en) | 2023-07-18 |
| MX385439B (es) | 2025-03-18 |
| AU2017259748B2 (en) | 2021-08-05 |
| BR112018072588B1 (pt) | 2024-02-20 |
| JP7078959B2 (ja) | 2022-06-01 |
| KR102428383B1 (ko) | 2022-08-02 |
| AU2017259748A1 (en) | 2018-12-20 |
| EA201892461A1 (ru) | 2019-04-30 |
| SG11201809845TA (en) | 2018-12-28 |
| EP3470414B1 (en) | 2021-10-13 |
| ES2902992T3 (es) | 2022-03-30 |
| NZ748959A (en) | 2024-02-23 |
| AR108369A1 (es) | 2018-08-15 |
| CN110114356B (zh) | 2021-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291784B1 (en) | Reducing systemic regulatory t cell levels or activity fortreatment of " disease and injury of the cns | |
| ZA201903333B (en) | Photovoltaic system and associated use | |
| IL276690A (en) | Neural microphysiological systems and methods for their use | |
| PL3407889T3 (pl) | Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego | |
| SG11202002159VA (en) | Absorbent article and related methods | |
| IL264813B (en) | 2-oxo-imidazopyridines and their use | |
| HRP20181681T1 (hr) | Sveterensko vozilo i ovjes za sveterensko vozilo | |
| EP3334429C0 (en) | HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR | |
| DK3292145T3 (da) | Fc-mutanter med modificeret funktionel aktivitet | |
| PL3362449T3 (pl) | Pochodne sybiriliny do zastosowania do zapobiegania i/lub leczenia zaburzeń związanych z nekroptozą komórkową | |
| IL259202A (en) | Modified immune cells and uses thereof | |
| DE112016005486A5 (de) | Sicherheitselement und mit demselben ausgestatteter Datenträger | |
| EP3523221C0 (de) | Regalbediengerät und regallagersystem mit verbesserter zugänglichkeit und gewichtsverteilung | |
| HUE048999T2 (hu) | Rendszer porlasztóval és tartállyal | |
| IL247435A0 (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| GB201507721D0 (en) | Immunosuppressive agents and their use in therapy | |
| DK3555279T3 (da) | Polypeptider med endoglucanase-aktivitet og anvendelser deraf | |
| EP3558450A4 (en) | NEUROSTIMULATORS AND STIMULATION SYSTEMS | |
| EP3466753A4 (en) | SEAT AND VEHICLE | |
| GB201410226D0 (en) | Methods and arrays for use in the same | |
| DK3481865T5 (da) | Fc-mutanter med forbedret funktionel aktivitet | |
| DK3275841T3 (da) | Primært filtrerings- og lagringssystem | |
| EP3466269A4 (en) | COMPOSITION CONTAINING CAFFEINE AND CYCLOALANYLALANINE | |
| EP3294589A4 (en) | SEAT STRUCTURE AND SEAT STRUCTURE WITH SEAT STRUCTURE | |
| HUE047553T2 (hu) | Dextrán-szaccharáz aktivitású protein és alkalmazásai |